This Government Contract opportunity was posted on August 4, 2010. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
The Synthesis and Preclinical Studies of New Treatments for Neurodegenerative Disease, Diabetes Mellitus, Congestive Heart Failure, Oncologic and Immunologic Disease.
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This award notice concerns a project titled The Synthesis and Preclinical Studies of New Treatments for Neurodegenerative Disease, Diabetes Mellitus, Congestive Heart Failure, Oncologic and Immunologic Disease, identified by solicitation number HHS-NIH-NIDA(AG)-RFP-09-006. The work falls under NAICS code 541712 and is managed by contracts specialists Tawanda Haynes and Craig D. Sager. While initial planning suggested a Cost-Reimbursement contract due to performance uncertainties, the government ultimately selected an Indefinite Delivery, Indefinite Quantity contract. This decision was based on historical data indicating a recurring need for services where precise quantities could not be predetermined above a specified minimum, making the IDIQ structure more suitable for the project requirements.
General Info
Agency
Contract Value
$1Place of Performance
N/A, USASet-Aside
Awardee
SRI INTERNATIONALAward Issued Date
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
